LAG3 and neoplasm: Lymphocyte-activation gene 3 (LAG3) and PD-1 are distinct inhibitory immune checkpoints often co-expressed on tumor-infiltrating lymphocytes and contributing to tumor-mediated T-cell exhaustion [2, 3].